Many other conditions can mimic the symptoms of prostate cancer, both in its early or advanced stages. Here's what you need ...

Rashes are a common side effect of some prostate cancer treatments. Rarely, they may be caused by cancer cells.

Bayer today showcased significant advancements in its pharmaceutical growth strategy and pipeline at its recent annual Pharma ...

The FDA approved several therapies in oncology in the month of March 2025. These drugs included treatments for ...

The Medical Oncology Association of Southern California (MOASC) presented the highly anticipated 2025 Cary Presant, MD Young Investigator Award to Dr. Peter Zang, MD, Fellow in Hematology & Medical ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that it has selected Cardinal ...

"2025 is set to be a landmark year for Bayer Pharmaceuticals. We are bringing a number of groundbreaking products and our ...

The company is expanding its cardiology portfolio with a new treatment for transthyretin amyloid cardiomyopathy in Europe.

However, there are often no or very slowly developing symptoms. In 2020 ... with over 15,000 new cases of metastatic prostate cancer confirmed annually. The prostate is a small gland that sits ...

Bayer heralds pipeline progress, blockbuster launches and advanced flagship products in cell-gene therapy: Our Bureau, Bengaluru Wednesday, April 2, 2025, 14:50 Hrs [IST] Bayer Ph ...

Every hour, one person in the United States dies from oral and oropharyngeal cancer. Yet, when detected early, the survival rate can be as high as 90 percent. This April, the American Association of ...

Global science company Bayer is gearing up to launch an array of groundbreaking products with blockbuster potential in 2025, a top company official said on Tuesday.